This study is the first to report that UHRF1 modulates adipogenesis through GPNMB and TGF-β activation, and it highlights the significance of studying UHRF1 and its targets as a potential therapeutic approach to obesity preventive healthcare. The gene discussed is TGFB1; the disease is obesity due to melanocortin 4 receptor deficiency.